Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Diabetes Mellitus
- Sponsor
- Korey Kennelty
- Enrollment
- 302
- Locations
- 12
- Primary Endpoint
- Adherence of medical regimen/treatment to all of the Guideline Advantage criteria that apply.
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
The trial will examine whether a centralized Prevention Health & Cardiovascular Risk Service (PHCVRS) run by clinical pharmacists at the University of Iowa can be implemented in primary care offices and whether it can improve the care delivered to patients at risk for developing cardiovascular disease.
Detailed Description
The use of clinical pharmacists in primary care has improved the control of several chronic cardiovascular conditions. However, many private physician practices lack the resources to implement team-based care with pharmacists. The purpose of this study was to evaluate whether a centralized, remote, clinical pharmacy service could improve guideline adherence and secondary measures of cardiovascular risk in primary care offices in rural and small communities. This study was a prospective trial in 12 family medicine offices cluster randomized to either the intervention or usual care. The intervention was delivered for 12 months, and subjects had research visits at baseline and 12 months. The primary outcome was adherence to guidelines, and secondary outcomes included changes in key cardiovascular risk factors and preventative health measures. We enrolled 302 subjects.
Investigators
Korey Kennelty
Assistant Professor
University of Iowa
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Adherence of medical regimen/treatment to all of the Guideline Advantage criteria that apply.
Time Frame: 12 months for each participant
The primary outcome measure was adherence to the GA criteria as a surrogate for quality of care because each subject had varying gaps in guideline-concordant care, depending on their specific cardiovascular conditions and preventative care needs.
Secondary Outcomes
- Control of blood pressure, low density lipoprotein cholesterol and hemoglobin A1c.(12 months for each participant)